Our mission is to transform the diagnosis and treatment of male reproductive problems. This section provides Healthcare Professionals with the latest clinical information and resources to support the management of their male patients.
SpermComet® is Examen’s market leading sperm DNA test. SpermComet® is a robust biomarker for male infertility, IVF and ICSI failure and miscarriage. Independent research has shown that it is the best performing sperm DNA test in terms of sensitivity, specificity and predictive power. SpermComet® is the only sperm DNA test guaranteed for oligozoospermic and testicular samples.
SpermComet® is indicated for use in conjunction with conventional semen analysis in the assessment of men experiencing reproductive problems, including recurrent miscarriage; men for whom ART is being considered; or men who have had failed implantation or miscarriage following ART.
Most sperm DNA damage tests measure the number of sperm with damage but not the amount of damage. In contrast, the SpermComet® quantifies the amount of DNA damage in individual sperm enabling the heterogeneity of the sperm population to be assessed. Understanding the variability of DNA damage within a sample strengthens the SpermComet’s® ability to diagnose male infertility and predict a live birth with IVF or ICSI.
SpermComet® is the only DNA test guaranteed for oligozoospermic and testicular samples, allowing it to be used in the assessment of all male patients. The Examen testing service can be set-up within your own Clinic. In the UK and Ireland, it can also be accessed on a referral basis through our Examen Hubs.